<DOC>
	<DOCNO>NCT02528331</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness repetitive TMS ( rTMS ) deliver simultaneously element cognitive behavioral therapy/exposure-response prevention ( CBT/ERP ) adult subject ( great equal 18 year old ) obsessive-compulsive disorder ( OCD ) . This open label study involve standard care OCD ( CBT ) investigational treatment modality ( TMS ) . The investigator compare Yale-Brown Obsessive Compulsive Scale ( YBOCS ) score treatment quantify clinical improvement . The side effect TMS include , limited , headache , seizure , general pain . CBT minimal side effect mental discomfort exposure session . For safety concern , pregnant woman subject seizure-related history exclude well indicated condition detail protocol .</brief_summary>
	<brief_title>Cognitive Behavioral Strategies Transcranial Magnetic Stimulation Obsessive-Compulsive Disorder : Open Label Study</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<criteria>Inclusion Criteria Subjects must meet follow inclusion criterion qualify enrollment study : 1 . All subject 18 65 year age . 2 . Obsessivecompulsive disorder : Subjects meet DSMIV primary diagnosis obsessivecompulsive YBOCS total score &gt; 16 3 . Subjects willing able adhere intensive treatment schedule require study visit . Exclusion Criteria Subjects exclude study participation one follow exclusion criterion applies : 1 . Subjects unable unwilling give inform consent . 2 . No exclusion criterion comorbid DSM diagnosis . 3 . Subjects clinically define neurological disorder cause significant safety concern receive TMS treatment , include , limited : Any condition likely associate increase intracranial pressure . Space occupy brain lesion . Any history seizure EXCEPT therapeutically induce ECT ( childhood febrile seizures acceptable subject may include study ) . History stroke . Transient ischemic attack within two year . Cerebral aneurysm . Dementia . Mini Mental Status Exam ( MMSE2 ) score &lt; 24 . Parkinson 's disease . Huntington 's disease . Multiple sclerosis . Increased risk seizure reason , include prior diagnosis increase intracranial pressure ( large infarction trauma ) , currently take medication lower seizure threshold . Medications low seizure threshold include Prohibited Concomitant Medication ( Section 5.8 ) . 4 . Subjects follow treatment history : TMS treatment within 6 month prior screen visit . Lifetime history treatment Deep Brain Stimulation Use investigational drug device within 4 week randomization visit . If participate psychotherapy , must stable treatment least 2 month prior entry study , anticipation change frequency therapeutic session , therapeutic focus duration trial . Recent 2month medication change 5 . Contraindication receive TMS : Cardiac pacemaker , implanted medication pump , intracardiac line , acute , unstable cardiac disease . Intracranial implant ( e.g. , aneurysm clip , shunt , stimulators , cochlear implant , stent , electrode ) metal object within near head , exclude mouth , safely remove . Clinically significant abnormality clinically significant unstable medical condition , indicate medical history , physical examination , ECG result , clinical laboratory testing , Investigator 's judgment might pose potential safety risk subject limit interpretation trial result , e.g. , uncontrolled thyroid disorder , hepatic , cardiac , pulmonary renal malfunctioning . 6 . Women currently pregnant use medically acceptable mean birth control woman breastfeed .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Transcranial magnetic stimulation ( TMS )</keyword>
	<keyword>Cognitive behavioral therapy ( CBT )</keyword>
</DOC>